{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:26:54Z","timestamp":1780471614075,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00296-013-2678-3","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T03:35:30Z","timestamp":1359603330000},"page":"2001-2007","source":"Crossref","is-referenced-by-count":13,"title":["Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNF\u03b1 therapy and discontinuation of glucocorticoids"],"prefix":"10.1007","volume":"33","author":[{"given":"Kristyna","family":"Brabnikova Maresova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Jarosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Stepan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"2678_CR1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.1780390506","volume":"39","author":"PH Pepmueller","year":"1996","unstructured":"Pepmueller PH, Cassidy JT, Allen SH, Hillman LS (1996) Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthr Rheum 39:746\u2013757","journal-title":"Arthr Rheum"},{"key":"2678_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1529-0131(200003)43:3<531::AID-ANR8>3.0.CO;2-X","volume":"43","author":"CJ Henderson","year":"2000","unstructured":"Henderson CJ, Specker BL, Sierra RI, Campaigne BN, Lovell DJ (2000) Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthr Rheum 43:531\u2013540","journal-title":"Arthr Rheum"},{"key":"2678_CR3","first-page":"1189","volume":"20","author":"J Reeve","year":"1993","unstructured":"Reeve J, Loftus J, Hesp R, Ansell BM, Wright DJ, Woo PM (1993) Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids. J Rheumatol 20:1189\u20131195","journal-title":"J Rheumatol"},{"key":"2678_CR4","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/art.11097","volume":"48","author":"G Lien","year":"2003","unstructured":"Lien G, Flato B, Haugen M, Vinje O, Sorskaar D, Dale K, Johnston V, Egeland T, Forre O (2003) Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. Arthr Rheum 48:2214\u20132223","journal-title":"Arthr Rheum"},{"key":"2678_CR5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1529-0131(199904)42:4<790::AID-ANR24>3.0.CO;2-G","volume":"42","author":"M Zak","year":"1999","unstructured":"Zak M, Hassager C, Lovell DJ, Nielsen S, Henderson CJ, Pedersen FK (1999) Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. Arthr Rheum 42:790\u2013798","journal-title":"Arthr Rheum"},{"key":"2678_CR6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.2005.048835","volume":"65","author":"JM Burnham","year":"2006","unstructured":"Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB (2006) Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the general practice research database. Ann Rheum Dis 65:1074\u20131079","journal-title":"Ann Rheum Dis"},{"key":"2678_CR7","author":"K Brabnikova Maresova","year":"2011","unstructured":"Brabnikova Maresova K (2011) Secondary osteoporosis in patients with juvenile idiopathic arthritis. J Osteoporos. doi: 10.4061\/2011\/569417","journal-title":"J Osteoporos"},{"key":"2678_CR8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","volume":"344","author":"MJ Elliott","year":"1994","unstructured":"Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H et al (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105\u20131110","journal-title":"Lancet"},{"key":"2678_CR9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","volume":"130","author":"LW Moreland","year":"1999","unstructured":"Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130:478\u2013486","journal-title":"Ann Intern Med"},{"key":"2678_CR10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric rheumatology collaborative study group. N Engl J Med 342:763\u2013769","journal-title":"N Engl J Med"},{"key":"2678_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.10710","volume":"48","author":"DJ Lovell","year":"2003","unstructured":"Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthr Rheum 48:218\u2013226","journal-title":"Arthr Rheum"},{"key":"2678_CR12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Kone-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debre M, Landais P, Prieur AM (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthr Rheum 48:1093\u20131101","journal-title":"Arthr Rheum"},{"key":"2678_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.62.3.245","volume":"62","author":"P Lahdenne","year":"2003","unstructured":"Lahdenne P, Vahasalo P, Honkanen V (2003) Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 62:245\u2013247","journal-title":"Ann Rheum Dis"},{"key":"2678_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","volume":"344","author":"AK Gough","year":"1994","unstructured":"Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23\u201327","journal-title":"Lancet"},{"key":"2678_CR15","first-page":"2481","volume":"34","author":"PF Vojvodich","year":"2007","unstructured":"Vojvodich PF, Hansen JB, Andersson U, Savendahl L, Hagelberg S (2007) Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis. J Rheumatol 34:2481\u20132485","journal-title":"J Rheumatol"},{"key":"2678_CR16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2005.047225","volume":"65","author":"P Tynjala","year":"2006","unstructured":"Tynjala P, Lahdenne P, Vahasalo P, Kautiainen H, Honkanen V (2006) Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann Rheum Dis 65:1044\u20131049","journal-title":"Ann Rheum Dis"},{"key":"2678_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/keh592","volume":"44","author":"G Simonini","year":"2005","unstructured":"Simonini G, Giani T, Stagi S, de Martino M, Falcini F (2005) Bone status over 1\u00a0year of etanercept treatment in juvenile idiopathic arthritis. Rheumatology (Oxford) 44:777\u2013780","journal-title":"Rheumatology (Oxford)"},{"key":"2678_CR18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.412","volume":"26","author":"AD Baxter-Jones","year":"2011","unstructured":"Baxter-Jones AD, Faulkner RA, Forwood MR, Mirwald RL, Bailey DA (2011) Bone mineral accrual from 8 to 30\u00a0years of age: an estimation of peak bone mass. J Bone Miner Res 26:1729\u20131739","journal-title":"J Bone Miner Res"},{"key":"2678_CR19","first-page":"1296","volume":"29","author":"D Simon","year":"2002","unstructured":"Simon D, Fernando C, Czernichow P, Prieur AM (2002) Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 29:1296\u20131300","journal-title":"J Rheumatol"},{"key":"2678_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"2678_CR21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocd.2007.12.007","volume":"11","author":"S Baim","year":"2008","unstructured":"Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S (2008) Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11:75\u201391","journal-title":"J Clin Densitom"},{"key":"2678_CR22","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","volume":"54","author":"DJ Lovell","year":"2006","unstructured":"Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH (2006) Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthr Rheum 54:1987\u20131994","journal-title":"Arthr Rheum"},{"key":"2678_CR23","doi-asserted-by":"crossref","unstructured":"Goldring SR (2003) Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42(Suppl 2):ii11\u201316","DOI":"10.1093\/rheumatology\/keg327"},{"key":"2678_CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","volume":"46","author":"K Redlich","year":"2002","unstructured":"Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Turk B, Pietschmann P, Woloszczuk W, Haralambous S, Kollias G, Steiner G, Smolen JS, Schett G (2002) Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthr Rheum 46:785\u2013792","journal-title":"Arthr Rheum"},{"key":"2678_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11154-007-9070-0","volume":"9","author":"A Viswanathan","year":"2008","unstructured":"Viswanathan A, Sylvester FA (2008) Chronic pediatric inflammatory diseases: effects on bone. Rev Endocr Metab Disord 9:107\u2013122","journal-title":"Rev Endocr Metab Disord"},{"key":"2678_CR26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115:282\u2013290","journal-title":"J Clin Invest"},{"key":"2678_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2008.04.004","volume":"39","author":"C Barnabe","year":"2009","unstructured":"Barnabe C, Hanley DA (2009) Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Semin Arthritis Rheum 39:116\u2013122","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 3","key":"2678_CR28","doi-asserted-by":"crossref","first-page":"iii10","DOI":"10.1093\/rheumatology\/keh202","volume":"43","author":"V Strand","year":"2004","unstructured":"Strand V, Kavanaugh AF (2004) The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology (Oxford) 43(Suppl 3):iii10\u2013iii16","journal-title":"Rheumatology (Oxford)"},{"key":"2678_CR29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1210\/jc.2004-2212","volume":"91","author":"D Michalska","year":"2006","unstructured":"Michalska D, Stepan JJ, Basson BR, Pavo I (2006) The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 91:870\u2013877","journal-title":"J Clin Endocrinol Metab"},{"key":"2678_CR30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2007.12.224","volume":"42","author":"LF Bonewald","year":"2008","unstructured":"Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42:606\u2013615","journal-title":"Bone"},{"key":"2678_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","volume":"544","author":"W Vanden Berghe","year":"2003","unstructured":"Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G (2003) A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol 544:181\u2013196","journal-title":"Adv Exp Med Biol"},{"key":"2678_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","volume":"321","author":"MS Nanes","year":"2003","unstructured":"Nanes MS (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1\u201315","journal-title":"Gene"},{"key":"2678_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"S Kwan Tat","year":"2004","unstructured":"Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y (2004) IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49\u201360","journal-title":"Cytokine Growth Factor Rev"},{"key":"2678_CR34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1359\/jbmr.070121","volume":"22","author":"Y Li","year":"2007","unstructured":"Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN (2007) Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NFkappaB. J Bone Miner Res 22:646\u2013655","journal-title":"J Bone Miner Res"},{"key":"2678_CR35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163","journal-title":"Nat Med"},{"key":"2678_CR36","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/keq123","volume":"49","author":"AD Billiau","year":"2010","unstructured":"Billiau AD, Loop M, Le PQ, Berthet F, Philippet P, Kasran A, Wouters CH (2010) Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis. Rheumatology (Oxford) 49:1550\u20131558","journal-title":"Rheumatology (Oxford)"},{"key":"2678_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MPG.0b013e3181edd797","volume":"52","author":"S Malik","year":"2011","unstructured":"Malik S, Wong SC, Bishop J, Hassan K, McGrogan P, Ahmed SF, Russell RK (2011) Improvement in growth of children with Crohn disease following anti-TNF-alpha therapy can be independent of pubertal progress and glucocorticoid reduction. J Pediatr Gastroenterol Nutr 52:31\u201337","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2678_CR38","first-page":"PI13","volume":"13","author":"R Rahimi","year":"2007","unstructured":"Rahimi R, Nikfar S, Abdollahi M (2007) Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit 13:PI13\u2013PI18","journal-title":"Med Sci Monit"},{"key":"2678_CR39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/ard.2005.044198","volume":"65","author":"M Vis","year":"2006","unstructured":"Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF (2006) Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65:1495\u20131499","journal-title":"Ann Rheum Dis"},{"key":"2678_CR40","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","volume":"6","author":"M Thayu","year":"2008","unstructured":"Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW, Heuschkel RB, Veereman-Wauters G, Griffiths AM, Baldassano RN (2008) Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn\u2019s disease: results of the REACH study. Clin Gastroenterol Hepatol 6:1378\u20131384","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2678_CR41","doi-asserted-by":"crossref","unstructured":"Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11 Suppl 6:S2\u201317","DOI":"10.1007\/s001980070002"},{"key":"2678_CR42","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/me.2009-0069","volume":"23","author":"LC Hofbauer","year":"2009","unstructured":"Hofbauer LC, Rauner M (2009) Minireview: live and let die: molecular effects of glucocorticoids on bone cells. Mol Endocrinol 23:1525\u20131531","journal-title":"Mol Endocrinol"},{"key":"2678_CR43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274\u2013282","journal-title":"J Clin Invest"},{"key":"2678_CR44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00198-009-0978-y","volume":"21","author":"A Szappanos","year":"2010","unstructured":"Szappanos A, Toke J, Lippai D, Patocs A, Igaz P, Szucs N, Futo L, Glaz E, Racz K, Toth M (2010) Bone turnover in patients with endogenous Cushing\u2019s syndrome before and after successful treatment. Osteoporos Int 21:637\u2013645","journal-title":"Osteoporos Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2678-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2678-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2678-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:44Z","timestamp":1559028104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2678-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2678-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}